🔎 Trials Near Me

Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Alabama

Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Alabama

4 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Alabama.

Cities in Alabama

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  • University of Alabama at Birmingham - 1720 University Blvd, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  • University of Alabama, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Alabama Neurology Associates- Site Number : 8400019, Homewood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  • Clinical Study Site, Birmingham
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.